Literature DB >> 12006606

Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice.

Greg I Elmer1, Jeanne O Pieper, Marcelo Rubinstein, Malcolm J Low, David K Grandy, Roy A Wise.   

Abstract

The rewarding effects of opiates are thought to be mediated through dopaminergic mechanisms in the ventral tegmental area, dopamine-independent mechanisms in the nucleus accumbens, or both. The purpose of the present study was to explore the contribution of dopamine to opiate-reinforced behavior using D2 receptor knock-out mice. Wild-type, heterozygous, and D2 knock-out mice were first trained to lever press for water reinforcement and then implanted with intravenous catheters. The ability of intravenously delivered morphine to maintain lever pressing in these mice was studied under two schedules of reinforcement: a fixed ratio 4 (FR4) schedule (saline, 0.1, 0.3, or 1.0 mg/kg, per injection) and a progressive ratio (PR) schedule (1.0 mg/kg, per injection). In the wild-type and heterozygous mice, FR4 behavior maintained by morphine injections was significantly greater than behavior maintained by vehicle injections. Response rate was inversely related to injection dose and increased significantly in the wild-type and heterozygous mice when the animals were placed on the PR schedule. In contrast, the knock-out mice did not respond more for morphine than for saline and did not respond more when increased ratios were required by the PR schedule. Thus, morphine served as a positive reinforcer in the wild-type and heterozygous mice but failed to do so in the knock-out mice. Under this range of doses and response requirements, the rewarding effects of morphine appear to depend critically on an intact D2 receptor system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006606      PMCID: PMC6757659          DOI: 20026412

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  28 in total

1.  Choice for response alternatives differing in reinforcement frequency in dopamine D2 receptor mutant and Swiss-Webster mice.

Authors:  Paul L Soto; Takato Hiranita; David K Grandy; Jonathan L Katz
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  Behavioral economics of food reinforcement and the effects of prefeeding, extinction, and eticlopride in dopamine D2 receptor mutant mice.

Authors:  Paul L Soto; David K Grandy; Steven R Hursh; Jonathan L Katz
Journal:  Psychopharmacology (Berl)       Date:  2011-02-02       Impact factor: 4.530

Review 3.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

4.  Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.

Authors:  Harshini Neelakantan; Sara Jane Ward; Ellen Ann Walker
Journal:  Exp Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.157

5.  Gentiopicroside attenuates morphine rewarding effect through downregulation of GluN2B receptors in nucleus accumbens.

Authors:  Shui-Bing Liu; Lan Ma; Hong-Ju Guo; Bin Feng; Yan-Yan Guo; Xiao-Qiang Li; Wen-Ji Sun; Lian-He Zheng; Ming-Gao Zhao
Journal:  CNS Neurosci Ther       Date:  2012-05-24       Impact factor: 5.243

Review 6.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

7.  Endogenous opioid-dopamine neurotransmission underlie negative CBV fMRI signals.

Authors:  Yen-Yu I Shih; Yun-Chen Chiang; Bai-Chuang Shyu; Fu-Shan Jaw; Timothy Q Duong; Chen Chang
Journal:  Exp Neurol       Date:  2012-01-05       Impact factor: 5.330

8.  Evidence for differential opioid use disorder in schizophrenia in an addiction treatment population.

Authors:  Joshua Chiappelli; Shuo Chen; Ann Hackman; L Elliot Hong
Journal:  Schizophr Res       Date:  2017-05-06       Impact factor: 4.939

9.  Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice.

Authors:  G I Elmer; J O Pieper; J Levy; M Rubinstein; M J Low; D K Grandy; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

10.  Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration.

Authors:  Greg I Elmer; Jeanne O Pieper; Lindsey R Hamilton; Roy A Wise
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.